OCTREOTYN
Dead / Cancelled — Cancelled — Section 8 (as of 05 Nov 2010)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78236282
- Registration number
- 2828012
- Mark type
- Word mark
- Filed
- 10 Apr 2003
- Published for opposition
- 06 Jan 2004
- Registered
- 30 Mar 2004
- Attorney of record
- Steven H. Hartman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the tretment of dermatology, in oncology, for use in the gastroenterological area, and the prevention and treatment of ocular disorders or diseases
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prosecution history
- 05 Nov 2010 — CANCELLED SEC. 8 (6-YR)
- 19 Jun 2009 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Mar 2004 — REGISTERED-PRINCIPAL REGISTER
- 06 Jan 2004 — PUBLISHED FOR OPPOSITION
- 17 Dec 2003 — NOTICE OF PUBLICATION
- 12 Nov 2003 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Oct 2003 — Sec. 1(B) CLAIM DELETED
- 27 Oct 2003 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 28 Oct 2003 — EMAIL RECEIVED
- 25 Sept 2003 — LETTER OF SUSPENSION E-MAILED
- 23 Sept 2003 — ASSIGNED TO EXAMINER